APA (7th ed.) Citation

Rubin Cheng, Yilan Huang, Yun Fang, Qirui Wang, Meixiu Yan, & Yuqing Ge. (2021). Cryptotanshinone enhances the efficacy of Bcr-Abl tyrosine kinase inhibitors via inhibiting STAT3 and eIF4E signalling pathways in chronic myeloid leukaemia. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Rubin Cheng, Yilan Huang, Yun Fang, Qirui Wang, Meixiu Yan, and Yuqing Ge. Cryptotanshinone Enhances the Efficacy of Bcr-Abl Tyrosine Kinase Inhibitors via Inhibiting STAT3 and EIF4E Signalling Pathways in Chronic Myeloid Leukaemia. Taylor & Francis Group, 2021.

MLA (9th ed.) Citation

Rubin Cheng, et al. Cryptotanshinone Enhances the Efficacy of Bcr-Abl Tyrosine Kinase Inhibitors via Inhibiting STAT3 and EIF4E Signalling Pathways in Chronic Myeloid Leukaemia. Taylor & Francis Group, 2021.